Arben Ventures
VC Fund
Arben Ventures is a VC fund focused on Health Care and Biotechnology. Arben Ventures invests in early-stage startups that can redefine health care domains.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Arben Ventures invests in
Stages Arben Ventures invests in
Countries Arben Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
|
|||
Investment Focus
Industry
- Health Care 2 (40%)
- Biotechnology 2 (40%)
- Artificial Intelligence 2 (40%)
- Fitness 1 (20%)
- Medical 1 (20%)
Stage
- Pre-Seed 2 (40%)
- Seed 1 (20%)
- Series A 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- United Kingdom 2 (40%)
- Canada 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ariel Ganz
Founding Partner
|
Founding Partner | Total investments: 0 | Find email | |
|
Benjamin Rolnik
Co-Founding Partner
|
Co-Founding Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Genie Fertility is a company specializing in precision care for uterine health. Their discovery platform non-invasively analyzes molecular biomarkers in the uterus lining using menstrual blood, focusing on the endometrium—the inner lining rich in unique reproductive data inaccessible through normal blood tests. This platform leverages multi-omicsand machine learning to unlock new reproductive health markers and therapies. | $1.2M / Pre-Seed / Sep 29, 2025 | |
|
|
Empo Health is an in-home health monitoring that fits seamlessly into patients' lives. | $7M / Venture - Series Unknown / Jun 24, 2025 | |
|
|
Allia Health provides a digital platform for mental health professionals, integrating tools for client onboarding, scheduling, treatment planning, and progress tracking. The platform features secure, HIPAA-compliant telehealth services with AI-assisted documentation to streamline clinical workflows. It collects real-world data through clientcheck-ins, symptom tracking, and optional wearable integrations, offering clinicians insights into patient progress between sessions. Allia Health operates on a model where individual clinicians access the platform at no cost, while larger healthcare organizations pay for enterprise features and analytics. The platform is accessible via iOS, Android, and web applications. | $2M / Seed / Jun 18, 2025 | |
|
|
Sentinal4D is an AI-powered biotechnology company focused on cancer drug discovery and development. The company leverages artificial intelligence models to generate personalized diagnoses tailored to a patient's tumor at the single-cell level. Sentinal4D operates within the Dynamical Cell Systems lab at the Institute of Cancer Research inLondon, utilizing 3D cell imaging technology to advance its research and development efforts. | Pre-Seed / Dec 20, 2024 | |
|
|
Othership provides emotional wellness service through social bathhouse experiences and a breathwork. | $8M / Series A / Jan 24, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Arben Ventures invest in?
Arben Ventures invests primarily in Health Care, Biotechnology and Artificial Intelligence startups, most often at Pre-Seed and Seed stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Arben Ventures?
Public channels for Arben Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Arben Ventures?
The team at Arben Ventures includes Ariel Ganz (Founding Partner) and Benjamin Rolnik (Co-Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!